- PR Newswire•22 days agoRoche introduces virtual reality theater at AACC 2016 Clinical Lab Expo to give lab professionals firsthand glimpse of connected lab of the future
The virtual reality theater will enable attendees to view samples moving through a virtual lab equipped with various configurations of Roche automation, chemistry/immunoassay platforms and molecular diagnostics systems, as well as connections to third-party platforms. The actual Roche systems that are part of the connected lab concept will also be on display in the booth.
- PR Newswire•22 days ago
OTCQX:RHHBY) today announced the global launch of the new HEAT-Seq¹ Target Enrichment Systems that provide rapid and accurate enrichment methods designed to improve the detection of variants in human genetics and cancer research. Molecular barcodes, or Unique Identifiers (UIDs), enable users to more accurately measure how much sequence data came from the sample itself, how much was unique and how much was redundant due to amplification during the PCR process. "The launch of our HEAT-Seq Target Enrichment Systems builds on Roche's commitment to driving the development of new tools for genomic medicine," said Neil Gunn, Head of Roche Sequencing Solutions.
- PR Newswire•23 days ago
PLEASANTON, Calif., Aug. 1, 2016 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the US Food and Drug Administration (FDA) has granted 510(k) clearance and CLIA (Clinical Laboratory ...
ROCHE HLDG (RO.SW)
Swiss - Swiss Delayed Price. Currency in CHF
|Bid||242.00 x 3700|
|Ask||246.50 x 22300|
|Day's Range||242.40 - 246.40|
|52wk Range||233.70 - 280.00|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||N/A|
|Avg Vol (3m)||20,132|
|Dividend & Yield||N/A (N/A)|